We are live on ! Find out more
LS

Livforsakringsbolaget Skandia Portfolio holdings

AUM $2.58B
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$1.89B
AUM Growth
+$29.4M
Cap. Flow
-$29.2M
Cap. Flow %
-1.54%
Top 10 Hldgs %
40.85%
Holding
614
New
19
Increased
46
Reduced
135
Closed
42

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.6M
2
URI icon
United Rentals
URI
+$16.2M
3
V icon
Visa
V
+$15.4M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.9M
5
UTHR icon
United Therapeutics
UTHR
+$10.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$13.6M
2
FERG icon
Ferguson
FERG
+$11.1M
3
AMD icon
Advanced Micro Devices
AMD
+$7.7M
4
PFE icon
Pfizer
PFE
+$7.2M
5
ANET icon
Arista Networks
ANET
+$5.93M

Sector Composition

Rank Sector Weight
1 Technology 35.53%
2 Consumer Discretionary 15.92%
3 Financials 13.7%
4 Healthcare 11.36%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
26
Qualcomm
QCOM
$174B
$13.2M 0.7%
86,111
-1,900
-2% -$311K
COST icon
27
Costco
COST
$423B
$13.1M 0.69%
14,291
-200
-1% -$186K
AMGN icon
28
Amgen
AMGN
$226B
$12.3M 0.65%
47,218
-100
-0.2% -$29.7K
HIG icon
29
Hartford Financial Services
HIG
$37.8B
$12.1M 0.64%
110,565
-500
-0.5% -$58K
FOXA icon
30
Fox Class A
FOXA
$27B
$11.3M 0.6%
233,700
BKNG icon
31
Booking.com
BKNG
$160B
$11.3M 0.6%
57,100
+27,125
+90% +$5.21M
GDDY icon
32
GoDaddy
GDDY
$11.8B
$11.3M 0.6%
57,300
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$133B
$11.2M 0.59%
27,820
+25,640
+1,176% +$11.9M
FCNCA icon
34
First Citizens BancShares
FCNCA
$25.8B
$10.9M 0.57%
5,149
-100
-2% -$210K
MCK icon
35
McKesson
MCK
$101B
$10.8M 0.57%
19,032
+7,650
+67% +$4.28M
SE icon
36
Sea Limited
SE
$76.6B
$10.8M 0.57%
101,800
GM icon
37
General Motors
GM
$76.4B
$10.6M 0.56%
199,011
AZO icon
38
AutoZone
AZO
$50.5B
$10.4M 0.55%
3,261
-120
-4% -$380K
ELV icon
39
Elevance Health
ELV
$87.6B
$10.3M 0.55%
28,036
+200
+0.7% +$83.7K
PCAR icon
40
PACCAR
PCAR
$68.8B
$10.2M 0.54%
95,397
SNA icon
41
Snap-on
SNA
$21B
$10M 0.53%
29,600
KR icon
42
Kroger
KR
$34.8B
$10M 0.53%
164,286
UTHR icon
43
United Therapeutics
UTHR
$21.7B
$9.9M 0.52%
28,100
+27,700
+6,925% +$10.2M
CI icon
44
Cigna
CI
$73.8B
$9.86M 0.52%
35,717
CAT icon
45
Caterpillar
CAT
$393B
$9.81M 0.52%
27,052
+22,850
+544% +$8.86M
AMAT icon
46
Applied Materials
AMAT
$440B
$9.45M 0.5%
58,107
ADBE icon
47
Adobe
ADBE
$105B
$9.28M 0.49%
20,872
EXPE icon
48
Expedia Group
EXPE
$38.9B
$9.17M 0.49%
49,237
HD icon
49
Home Depot
HD
$345B
$9.15M 0.48%
23,524
-200
-0.8% -$81.7K
CAH icon
50
Cardinal Health
CAH
$54.1B
$9.08M 0.48%
76,799
+71,000
+1,224% +$8.29M

Similar funds

Livforsakringsbolaget Skandia's Q4 2024 Portfolio in Review

As of Q4 2024, Livforsakringsbolaget Skandia held 614 positions worth $1.89B, up 1.6% from $1.86B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Livforsakringsbolaget Skandia's Q4 2024 filing shows 19 new, 46 increased, 135 reduced and 42 closed positions. Its largest new stake was Unum: 67,500 shares worth $4.93M. The largest sale was Merck, an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Livforsakringsbolaget Skandia's largest Q4 2024 buy was Unum: 67,500 shares worth $4.93M.
  • Livforsakringsbolaget Skandia added most to UnitedHealth in Q4 2024, an estimated $18.6M increase.
  • Livforsakringsbolaget Skandia's biggest Q4 2024 reduction was Merck, cutting an estimated $13.6M.
  • Livforsakringsbolaget Skandia fully exited Catalyst Pharmaceutical in Q4 2024, selling an estimated $2.2M.
  • Livforsakringsbolaget Skandia's ten largest holdings make up 41% of its $1.89B portfolio in Q4 2024.
  • Livforsakringsbolaget Skandia opened 19 new positions and closed 42 in Q4 2024.
  • Livforsakringsbolaget Skandia's portfolio value rose 1.6% quarter-over-quarter to $1.89B.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2024, filed 28 Jan 2025.